Brevetti EPO No.2941251 2018.03.07
Brevetti EPO
(10) Registration Number and Date
2018000185 2018.04.16
Status
Expired
(180) Expiration Date
(20) Filing Number and Date
SM /T/2018/000185 2013.10.13
(40) Publication Number and Date
SM /T/2018/000185 2018.04.16
(30) Priority Details
US 201361749695 P
2013.01.07
(51) IPC Classes
(71/73) Applicant
(IT) AROG PHARMACEUTICALS, INC. : 5420 LBJ Freeway Suite 410, Dallas, TX 75240, US
(72) Inventor
(IT) JAIN, Vinay, K. : 10710 Inwood Road, Dallas, TX 75229, US
(74) Representative Name
(IT) DE BENEDETTI, Jacopo : Via L. Cibrario, 25, 47893 Borgo Maggiore RSM , SM
(54) Title
(IT) CRENOLANIB PER TRATTARE DISTURBI PROLIFERATIVI CON FLT3 MUTATO
(EN) CRENOLANIB FOR TREATING FLT3 MUTATED PROLIFERATIVE DISORDERS
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2020.06.09
Event NameDateStatus
Filing2013.10.13Filed
PCT National Phase Filing2013.10.14PCT National Phase
Brevetto EPO concesso2018.04.16Published
Ricevuta pagamento annualita 62018.09.25Payed
Ricevuta pagamento annualita 72019.09.25Payed
Ricevuta pagamento annualita 82020.09.23Payed
Ricevuta pagamento annualita 92021.09.23Payed
Decaduto per non pagamento tassa2023.05.22Expired